STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $10,980,000 | -75.9% | 1,155,793 | -57.9% | 0.81% | -67.1% |
| Q3 2018 | $45,603,000 | +3.4% | 2,747,198 | 0.0% | 2.46% | -13.7% |
| Q2 2018 | $44,093,000 | +10.6% | 2,747,198 | +5.4% | 2.84% | -22.0% |
| Q1 2018 | $39,881,000 | +8.8% | 2,606,598 | +10.9% | 3.64% | +10.1% |
| Q4 2017 | $36,657,000 | +3155.5% | 2,349,792 | +2216.9% | 3.31% | +2548.8% |
| Q3 2017 | $1,126,000 | – | 101,420 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |